GXP ACADEMY · GXP INSIGHTS

From GxP requirements to stronger quality systems.

Practical analysis of GMP, Pharmaceutical Quality Systems, deviations, CAPA, change control, audits and risk management. Built to support sound interpretation, defensible decisions and stronger evidence.

✓ EU GMP · FDA · ICH ✓ Audits and inspections ✓ Applicable methods

ANALYSIS & PRACTICAL GUIDES

Insights that turn compliance into action.

Quality systems, audit readiness and GMP processes explained through concrete criteria, examples and practical points of attention.

54 articles available

EVERY MONDAY · 7 MINUTES

Bring GMP updates into your week.

The Pragmatic GMP turns one topic, one real-world example and inspection trends into practical guidance.
Discover The Pragmatic GMP

GxP Insights

Come selezionare e supervisionare un provider QPPV esternalizzato nell’UE

How to Select and Oversee an Outsourced QPPV Pr...

A practical framework for MAHs to assess, appoint, transition and govern an outsourced QPPV provider without losing pharmacovigilance control.

How to Select and Oversee an Outsourced QPPV Pr...

A practical framework for MAHs to assess, appoint, transition and govern an outsourced QPPV provider without losing pharmacovigilance control.

ISO 14644-3 Recovery Test: procedura, calcolo e accettazione GMP

ISO 14644-3 Recovery Test: Procedure, Calculati...

A practical, inspection-ready approach to planning, running, calculating and defending cleanroom particle-recovery testing under ISO 14644-3 and EU GMP Annex 1.

ISO 14644-3 Recovery Test: Procedure, Calculati...

A practical, inspection-ready approach to planning, running, calculating and defending cleanroom particle-recovery testing under ISO 14644-3 and EU GMP Annex 1.

Responsabilità di MAH, QP e QPPV nella governance dei difetti di qualità e dei richiami

MAH, QP and QPPV Responsibilities for Quality D...

A practical GMP–pharmacovigilance governance model for assigning decision rights, escalating evidence and coordinating authority communications when a quality defect may affect patient safety.

MAH, QP and QPPV Responsibilities for Quality D...

A practical GMP–pharmacovigilance governance model for assigning decision rights, escalating evidence and coordinating authority communications when a quality defect may affect patient safety.

Good documentation practices GMP across paper, electronic and hybrid records

Good Documentation Practices in GMP: Records, C...

A practical, inspection-ready guide to controlling GMP records across paper, electronic and hybrid systems, using current EU GMP Chapter 4 as the baseline.

Good Documentation Practices in GMP: Records, C...

A practical, inspection-ready guide to controlling GMP records across paper, electronic and hybrid systems, using current EU GMP Chapter 4 as the baseline.

Quality professional reviewing FDA warning letter GMP findings and CAPA evidence

FDA Warning Letters: Recurring GMP Findings, Ro...

A practical, non-statistical analysis of recurring CGMP failure themes illustrated by selected FDA Warning Letters published in 2026, with audit questions and CAPA design actions.

FDA Warning Letters: Recurring GMP Findings, Ro...

A practical, non-statistical analysis of recurring CGMP failure themes illustrated by selected FDA Warning Letters published in 2026, with audit questions and CAPA design actions.

Process validation pharma: ciclo di vita, PPQ, CPV e checklist FDA/UE GMP

Process Validation in Pharma: Lifecycle, PPQ, C...

A practical lifecycle guide to process validation in pharma, covering process design, PPQ, continued process verification and Annex 15 alignment.

Process Validation in Pharma: Lifecycle, PPQ, C...

A practical lifecycle guide to process validation in pharma, covering process design, PPQ, continued process verification and Annex 15 alignment.